Doctors in Cambridge believe they are “on the brink of a new class of treatments” for multiple sclerosis (MS) after a trial ...
For decades, multiple sclerosis (MS) research has focused largely on the inflammatory lesions visible on MRI scans. Yet new ...
Providing evidence for a new online MS assessment tool, researchers discovered the overlooked subtype in patients of all ages ...
The MIND diet significantly reduces disability and fatigue, improving quality of life for people with MS, a long-term study ...
MedPage Today on MSN
Novel Drug Shows Hints of Promise for Progressive MS
Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...
People with MS experience significant changes in cognition more than a year before significant physical decline is evident, a ...
The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s ...
15hon MSN
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will ...
We are delighted to present the inaugural Frontiers in Neurology "Women in Multiple Sclerosis and Neuroimmunology" series of ...
News-Medical.Net on MSN
Consumption of ultra-processed foods may exacerbate disease activity in early multiple sclerosis
Higher intake of ultra-processed foods (UPFs) may exacerbate disease activity in early multiple sclerosis (MS), according to ...
Major revisions to the diagnostic criteria for neuromyelitis optica spectrum disorder will broaden their scope to related syndromes and have a substantial clinical impact.
Harlow is a Great Dane, which is uncommon for a service dog, but Hall is also tall at 6 feet 3 inches. After spending 15 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results